Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Evolution of a US County System for Acute Comprehensive Stroke Care.

Raychev RI, Stradling D, Patel N, Gee JR, Lombardi DA, Moon JL, Brown DM, Pathak M, Yu W, Stratton SJ, Cramer SC.

Stroke. 2018 May;49(5):1217-1222. doi: 10.1161/STROKEAHA.118.020620. Epub 2018 Apr 6.

2.

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, House MG, Parnes HL, Bailey HH.

Cancer Prev Res (Phila). 2017 May;10(5):298-307. doi: 10.1158/1940-6207.CAPR-16-0167. Epub 2017 Mar 21.

3.

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH.

Eur J Cancer Prev. 2016 Jul;25(4):312-20. doi: 10.1097/CEJ.0000000000000189.

PMID:
26313229
4.

Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.

Kowalik C, Gee JR, Sorcini A, Moinzadeh A, Canes D.

Can J Urol. 2014 Jun;21(3):7266-70.

PMID:
24978355
5.

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.

Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI.

J Urol. 2014 Oct;192(4):1081-7. doi: 10.1016/j.juro.2014.04.013. Epub 2014 Apr 18.

6.

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.

Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):4-15. doi: 10.1016/j.eururo.2012.09.057. Epub 2012 Oct 4. Review.

PMID:
23083902
7.

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, Kolesar J, Harris L, Faerber A, Havighurst T, Young JM, Efros M, Getzenberg RH, Wheeler MA, Tangrea J, Parnes H, House M, Busby JE, Hohl R, Bailey H.

Cancer Prev Res (Phila). 2012 Apr;5(4):621-30. doi: 10.1158/1940-6207.CAPR-11-0455. Epub 2012 Jan 31.

8.

Neurochemical changes following a single dose of polybrominated diphenyl ether 47 in mice.

Gee JR, Moser VC, McDanie KL, Herr DW.

Drug Chem Toxicol. 2011 Apr;34(2):213-9. doi: 10.3109/01480545.2010.536768.

PMID:
21314472
9.

A Bayesian adaptive design with biomarkers for targeted therapies.

Eickhoff JC, Kim K, Beach J, Kolesar JM, Gee JR.

Clin Trials. 2010 Oct;7(5):546-56. doi: 10.1177/1740774510372657. Epub 2010 Jun 22.

10.

BCAN Think Tank session 3: Prevention of bladder cancer.

Lerner SP, Grossman HB, Messing EM, Kibel AS, Stephenson A, Gee JR, O'Donnell MA, Reid RD, Kamat AM, Parnes HL, House MG.

Urol Oncol. 2010 May-Jun;28(3):338-42. doi: 10.1016/j.urolonc.2009.06.018.

PMID:
20439034
11.

Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Gee JR, Burmeister CB, Havighurst TC, Kim K.

Anticancer Res. 2009 Oct;29(10):3769-75.

12.

Flexible and rigid cystoscopy in women.

Gee JR, Waterman BJ, Jarrard DF, Hedican SP, Bruskewitz RC, Nakada SY.

JSLS. 2009 Apr-Jun;13(2):135-8.

13.

Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.

Gee JR, Jarrard DF, Bruskewitz RC, Moon TD, Hedican SP, Leverson GE, Nakada SY, Messing EM.

BJU Int. 2009 Mar;103(6):736-9. doi: 10.1111/j.1464-410X.2008.08123.x. Epub 2008 Oct 31.

14.

Lack of alterations in thyroid hormones following exposure to polybrominated diphenyl ether 47 during a period of rapid brain development in mice.

Gee JR, Hedge JM, Moser VC.

Drug Chem Toxicol. 2008;31(2):245-54. doi: 10.1080/01480540701873194 .

PMID:
18330785
15.

Acute postnatal exposure to brominated diphenylether 47 delays neuromotor ontogeny and alters motor activity in mice.

Gee JR, Moser VC.

Neurotoxicol Teratol. 2008 Mar-Apr;30(2):79-87. doi: 10.1016/j.ntt.2007.11.001. Epub 2007 Dec 3.

PMID:
18166377
16.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL.

Cancer. 2007 Jul 1;110(1):62-7.

17.

Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain.

Gee JR, Ding Q, Keller JN.

Biogerontology. 2006 Apr;7(2):69-79.

PMID:
16802110
18.

Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques.

Pareek G, Hedican SP, Gee JR, Bruskewitz RC, Nakada SY.

J Urol. 2006 Apr;175(4):1208-13.

PMID:
16515961
19.

The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

Kamat AM, Gee JR, Dinney CP, Grossman HB, Swanson DA, Millikan RE, Detry MA, Robinson TL, Pisters LL.

J Urol. 2006 Mar;175(3 Pt 1):881-5. Erratum in: J Urol. 2006 May;175(5):1967.

PMID:
16469571
20.

The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.

Gee JR, Chang J, Dublin AB, Vijayan N.

Headache. 2005 Jun;45(6):670-7.

PMID:
15953299
21.

Modulation of apolipoprotein E and interleukin-1beta in the aging liver.

Gee JR, Ding Q, Keller JN.

Exp Gerontol. 2005 May;40(5):409-15. Epub 2005 Feb 23.

PMID:
15919593
22.

Astrocytes: regulation of brain homeostasis via apolipoprotein E.

Gee JR, Keller JN.

Int J Biochem Cell Biol. 2005 Jun;37(6):1145-50. Review.

PMID:
15778078
23.

Loss of an individual proteasome subunit alters motor function but not cognitive function or ambulation in mice.

Martin S, Gee JR, Bruce-Keller AJ, Keller JN.

Neurosci Lett. 2004 Feb 26;357(1):76-8.

PMID:
15036617
24.

Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.

Gee JR, Montoya RG, Khaled HM, Sabichi AL, Grossman HB.

Urol Oncol. 2003 Jul-Aug;21(4):266-70.

PMID:
12954496
25.

Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology.

Tanaka M, Gee JR, De La Cerda J, Rosser CJ, Zhou JH, Benedict WF, Grossman HB.

J Urol. 2003 Sep;170(3):975-8.

PMID:
12913753
26.

Postcraniotomy headache.

Gee JR, Ishaq Y, Vijayan N.

Headache. 2003 Mar;43(3):276-8.

PMID:
12603648
27.

Successful management of metastatic urethral cancer with organ preservation.

Kent D, Gee JR, Amato RJ, Pisters LL.

J Urol. 2001 Dec;166(6):2308. No abstract available.

PMID:
11696764
28.

Cutaneous metastases of penile squamous cell carcinoma following en bloc resection of inguinal recurrence with immediate pedicle flap reconstruction.

Giesler EJ, Gee JR, Reece GP, Pettaway CA, Pollock RE, Pisters LL.

J Urol. 2001 Oct;166(4):1384-5. No abstract available.

PMID:
11547082
29.
30.

Scatter from fluid patches in optical thin-film coatings.

Gee JR, Hodgkinson IJ, Wilson PW.

Appl Opt. 1986 Aug 15;25(16):2688. No abstract available.

PMID:
18231543
31.

Moisture-dependent anisotropic effects in optical coatings.

Gee JR, Hodgkinson IJ, Macleod HA.

Appl Opt. 1985 Oct 1;24(19):3188. No abstract available.

PMID:
18224027

Supplemental Content

Support Center